Verition Fund Management LLC Cara Therapeutics, Inc. Transaction History

Verition Fund Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.52 - $1.05 $82,902 - $167,398	-159,427 Reduced 28.99%	390,602 $355,000
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.65 $96,000 - $264,000	160,000 Added 41.02%	550,029 $407,000
Q3 2023 Nov 14, 2023	SELL	$1.67 - $3.33 $100,151 - $199,703	-59,971 Reduced 13.33%	390,029 $655,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $1.21 Million - $2.11 Million	426,771 Added 1837.23%	450,000 $1.27 Million
Q1 2023 May 15, 2023	BUY	$4.89 - $12.27 $113,589 - $285,019	23,229 New	23,229 $114,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $250M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.